Valuation: Jamjoom Pharmaceuticals Factory Company

Capitalization 10.86B 2.9B 2.46B 2.25B 2.12B 3.96B 276B 3.99B 26.69B 10.42B 131B 10.64B 455B P/E ratio 2026 *
20.7x
P/E ratio 2027 * 18.7x
Enterprise value 10.55B 2.81B 2.39B 2.18B 2.06B 3.84B 268B 3.87B 25.91B 10.11B 128B 10.33B 441B EV / Sales 2026 *
6.52x
EV / Sales 2027 * 5.59x
Free-Float
39.1%
Yield 2026 *
2.89%
Yield 2027 * 3.21%

Last Transcript: Jamjoom Pharmaceuticals Factory Company

1 day-1.08%
1 week-0.19%
Current month-0.26%
1 month+1.31%
3 months+19.97%
6 months+2.24%
Current year+8.92%
1 week 151
Extreme 151
157.6
1 month 150.2
Extreme 150.2
157.8
Current year 125
Extreme 125
157.8
1 year 125
Extreme 125
183.8
3 years 66
Extreme 66
202.4
5 years 66
Extreme 66
202.4
10 years 66
Extreme 66
202.4
Manager TitleAgeSince
Chief Executive Officer 62 15/05/2021
Director of Finance/CFO 62 13/01/2013
Chief Operating Officer 31 01/09/2021
Director TitleAgeSince
Chairman 66 19/06/2022
Director/Board Member 41 19/06/2022
Director/Board Member 98 19/06/2022
Change 5d. change 1-year change 3-years change Capi.($)
-1.08%-0.19%-8.82% - 2.92B
+1.34%+3.56%+7.33%+96.34% 46.95B
-0.32%-2.05%+55.34%+132.69% 37.06B
-3.13%-0.36%-11.83%+38.17% 11.52B
+1.80%+7.29%+8.91%+82.07% 10.02B
+1.51%+2.05%+40.68%+121.33% 8.88B
-10.00%-15.95%+5.40%+23.88% 7.85B
-0.47%-0.94%+18.87%+51.81% 7.67B
-0.75%+6.33%+58.07%-5.47% 7.44B
-0.81%-2.45%+67.88%+311.84% 7.07B
Average -1.17%-0.24%+24.18%+94.74% 14.74B
Weighted average by Cap. -0.33%+0.23%+25.67%+100.58%

Financials

2026 *2027 *
Net sales 1.62B 431M 366M 335M 316M 589M 41.06B 594M 3.97B 1.55B 19.56B 1.58B 67.67B 1.87B 499M 423M 388M 365M 682M 47.51B 687M 4.6B 1.79B 22.63B 1.83B 78.3B
Net income 523M 139M 118M 108M 102M 191M 13.28B 192M 1.28B 501M 6.32B 512M 21.89B 581M 155M 131M 120M 113M 212M 14.75B 213M 1.43B 557M 7.03B 569M 24.32B
Net Debt -317M -84.49M -71.7M -65.66M -61.91M -115M -8.05B -116M -779M -304M -3.83B -310M -13.27B -404M -108M -91.37M -83.68M -78.9M -147M -10.26B -148M -992M -387M -4.89B -396M -16.91B
Logo Jamjoom Pharmaceuticals Factory Company
Jamjoom Pharmaceuticals Factory Company SJSC is a Saudi Arabia-based pharmaceutical company, which is primarily focused on developing, manufacturing, and distributing generic pharmaceuticals, cosmetics, and consumer healthcare products. It produces human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhoea, vomiting, and ulcer and acidity, among others. It operates in two segments: The Pharmaceutical products that represents medicines or drugs for the prevention and treatment of diseases, and protection of public health; and The Consumer health products that represents products used to support personal well-being, maintain health, or address specific health-related needs. The Company’s subsidiaries include Al Jamjoom Pharma for Pharmaceutical Industries and Jamjoom Pharmaceutical Industry and Commerce Company Limited and the Company also operates approximately 8 branches.
Employees
-
Date Price Change Volume
11/05/26 155.00 -1.08% 72,366
10/05/26 156.70 +1.75% 51,960
07/05/26 154.00 +1.32% 40,730
06/05/26 152.00 -1.30% 33,866
05/05/26 154.00 -0.84% 52,528
Trader
Investor
Global
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
155.00SAR
Average target price
164.24SAR
Spread / Average Target
+5.96%

Quarterly revenue - Rate of surprise